We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,031 hedge funds and large institutions have $164B invested in Thermo Fisher Scientific in 2020 Q4 according to their latest regulatory filings, with 275 funds opening new positions, 751 increasing their positions, 739 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

293% more first-time investments, than exits

New positions opened: 275 | Existing positions closed: 70

10% more funds holding

Funds holding: 1,8482,031 (+183)

5% more capital invested

Capital invested by funds: $156B → $164B (+$8.53B)

2% more repeat investments, than reductions

Existing positions increased: 751 | Existing positions reduced: 739

0.99% less ownership

Funds ownership: 89.16%88.17% (-0.99%)

7% less funds holding in top 10

Funds holding in top 10: 198184 (-14)

19% less call options, than puts

Call options by funds: $976M | Put options by funds: $1.21B

Holders
2,031
Holders Change
+183
Holders Change %
+9.9%
% of All Funds
35.93%
Holding in Top 10
184
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-7.07%
% of All Funds
3.26%
New
275
Increased
751
Reduced
739
Closed
70
Calls
$976M
Puts
$1.21B
Net Calls
-$229M
Net Calls Change
-$95M
Name Holding Trade Value Shares
Change
Change in
Stake
EI
976
Ethic Inc
New York
$2.5M +$677K +1,443 +37%
MFG
977
MidWestOne Financial Group
Iowa
$2.49M -$2.34K -5 -0.1%
VWA
978
V Wealth Advisors
Kansas
$2.49M +$2.23M +4,754 +795%
OAM
979
Optimal Asset Management
California
$2.47M
GSWM
980
Golden State Wealth Management
California
$2.46M +$1.79M +3,821 +262%
WCWM
981
Willow Creek Wealth Management
California
$2.46M -$45K -96 -2%
TEC
982
Tiger Eye Capital
Tennessee
$2.46M +$2.1M +4,469 +557%
FDS
983
Freedom Day Solutions
Texas
$2.45M +$2.34K +5 +0.1%
NAM
984
NTV Asset Management
West Virginia
$2.44M
NW
985
NewEdge Wealth
Pennsylvania
$2.44M +$2.46M +5,240 New
BCM
986
Bridgeway Capital Management
Texas
$2.42M +$2.2M +4,700 +940%
PCM
987
Palisade Capital Management
New Jersey
$2.4M +$9.38K +20 +0.4%
AA
988
ALPS Advisors
Colorado
$2.39M -$92.4K -197 -4%
PI
989
PFS Investments
Georgia
$2.38M +$478K +1,020 +28%
LWM
990
Laidlaw Wealth Management
New York
$2.37M +$1.43M +3,049 +150%
HWM
991
Hohimer Wealth Management
Washington
$2.37M -$30K -64 -1%
VPIM
992
Vanguard Personalized Indexing Management
California
$2.37M +$395K +842 +20%
OCA
993
Otter Creek Advisors
Florida
$2.36M -$1.71M -3,655 -42%
CPC
994
Cookson Peirce & Co
Pennsylvania
$2.33M +$62.4K +133 +3%
VFM
995
Viking Fund Management
North Dakota
$2.33M
WA
996
Wealth Advisors
California
$2.33M
PFPT
997
Pinnacle Financial Partners (Tennessee)
Tennessee
$2.33M -$45K -96 -2%
VLKIM
998
Van Lanschot Kempen Investment Management
Netherlands
$2.32M +$2.33M +4,975 New
Credit Agricole
999
Credit Agricole
France
$2.31M -$10.3M -22,059 -82%
VanEck Associates
1000
VanEck Associates
New York
$2.31M +$410K +875 +21%

TMO Hedge Fund Activity: Q4 2020 in Review

2,031 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2020, worth a combined $164B — up 5.5% from $156B a quarter earlier.

Buyers outnumbered sellers: 275 funds opened new TMO positions and 70 closed out — a net gain of 205 holders — while 751 added to existing stakes and 739 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $322M. The largest seller was Capital Research Global Investors, cutting an estimated $770M.

  • 2,031 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2020, up from 1,848 in Q3 2020.
  • Funds reported $164B of Thermo Fisher Scientific stock for Q4 2020, up 5.5% quarter-over-quarter.
  • 275 funds opened new Thermo Fisher Scientific positions in Q4 2020 and 70 closed out, a net change of +205 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2020 was Fidelity Investments, an estimated $322M added.
  • The largest Thermo Fisher Scientific seller in Q4 2020 was Capital Research Global Investors, an estimated $770M sold.

Based on aggregated 13F filings for Q4 2020.